F.D.A. to Ask Biotech Company to Stop Shipping Treatment Linked to Patient Deaths

Health
By Rebecca Robbins and Christina Jewett from NYT Health https://ift.tt/yfd70zE
via IFTTT Therapy and Rehabilitation, Biotechnology and Bioengineering, Genetic Engineering, Clinical Trials, Drugs (Pharmaceuticals), Deaths (Fatalities) Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Ele­vidys, or a similar treatment.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda